Galderma Laboratories

Galderma Laboratories is a pharmaceutical company dedicated to skin products and dermatology. The company's corporate headquarters are located in Paris, France. Other R&D sites include Sophia Antipolis, France, Tokyo, Japan, Fort Worth, Texas, USA & Cranbury, NJ, USA. The company manufactures various prescription topical products to treat acne (Differin), rosacea (MetroGel), and psoriasis (Clobex), and the over-the-counter Cetaphil line of facial and body cleansers and moisturizers. They also have, or are developing, treatments for fungal nail infections, seborrheic dermatitis, non-melanoma skin cancer and photodamage, and hyperpigmentation disorders. Galderma began in 1961 as Owen Laboratories in Fort Worth, and in 1981 joined forces with L'Oréal and Nestlé. The name became Owen-Galderma, and then Galderma.

Additional recommended knowledge

Guide to balance cleaning: 8 simple steps

Essential Laboratory Skills Guide

Safe Weighing Range Ensures Accurate Results

About Galderma Laboratories, L.P.

Created in 1981 as a joint venture between Nestlé and L'Oréal, Galderma Laboratories is one of the leading dermatology companies in the world according to recent IMS D-Class survey data. With a worldwide presence in 65 countries Galderma has over 1,000 sales representatives dedicated to dermatology. Galderma is a fully integrated specialty pharmaceutical company with a global sales and marketing structure and worldwide product development capability. Galderma provides innovative therapeutic skincare solutions to meet the needs of dermatology patients and physicians. The company is committed to improving the health of skin with an extensive line of products worldwide that treat a range of skincare conditions including: acne, rosacea, fungal nail infections, psoriasis, seborrheic dermatitis, hyper-pigmentation disorders, non-melanoma skin cancer and photo-damage.